XJPX7817
Market cap911mUSD
Jan 21, Last price
2,657.00JPY
1D
0.80%
1Q
5.86%
Jan 2017
13.79%
IPO
142.65%
Name
Paramount Bed Holdings Co Ltd
Chart & Performance
Profile
Paramount Bed Holdings Co., Ltd. manufactures and sells hospital and nursing care beds worldwide. The company offers mattresses and equipment for medical treatment and nursing care environments; and home care products. It also engages in the inspection and maintenance of Paramount bed products; and leasing and wholesale of welfare care products. The company was founded in 1947 and is headquartered in Tokyo, Japan.
IPO date
Oct 01, 2011
Employees
3,946
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 106,016,000 7.08% | 99,009,000 9.58% | 90,352,000 3.65% | |||||||
Cost of revenue | 94,065,000 | 87,683,000 | 80,074,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 11,951,000 | 11,326,000 | 10,278,000 | |||||||
NOPBT Margin | 11.27% | 11.44% | 11.38% | |||||||
Operating Taxes | 4,877,000 | 4,596,000 | 4,344,000 | |||||||
Tax Rate | 40.81% | 40.58% | 42.27% | |||||||
NOPAT | 7,074,000 | 6,730,000 | 5,934,000 | |||||||
Net income | 10,622,000 15.27% | 9,215,000 1.35% | 9,092,000 5.59% | |||||||
Dividends | (3,615,000) | (3,321,000) | (3,054,000) | |||||||
Dividend yield | 2.39% | 2.42% | 2.63% | |||||||
Proceeds from repurchase of equity | (2,399,000) | |||||||||
BB yield | 1.58% | |||||||||
Debt | ||||||||||
Debt current | 1,362,000 | 1,542,000 | 1,847,000 | |||||||
Long-term debt | 10,566,000 | 9,472,000 | 10,423,000 | |||||||
Deferred revenue | 7,005,000 | 6,807,000 | ||||||||
Other long-term liabilities | 7,995,000 | 619,000 | 653,000 | |||||||
Net debt | (58,980,000) | (65,558,000) | (63,927,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 7,521,000 | 9,151,000 | 7,822,000 | |||||||
CAPEX | (2,853,000) | (3,802,000) | (1,521,000) | |||||||
Cash from investing activities | (8,399,000) | (6,332,000) | (220,000) | |||||||
Cash from financing activities | (5,969,000) | (3,232,000) | (3,365,000) | |||||||
FCF | (4,184,000) | 1,932,000 | 4,493,000 | |||||||
Balance | ||||||||||
Cash | 46,746,000 | 53,232,000 | 54,069,000 | |||||||
Long term investments | 24,162,000 | 23,340,000 | 22,128,000 | |||||||
Excess cash | 65,607,200 | 71,621,550 | 71,679,400 | |||||||
Stockholders' equity | 93,173,000 | 83,535,000 | 76,868,000 | |||||||
Invested Capital | 84,365,800 | 67,794,450 | 61,187,600 | |||||||
ROIC | 9.30% | 10.44% | 9.78% | |||||||
ROCE | 7.64% | 7.80% | 7.43% | |||||||
EV | ||||||||||
Common stock shares outstanding | 58,173 | 58,191 | 58,142 | |||||||
Price | 2,604.00 10.43% | 2,358.00 18.20% | 1,995.00 -15.21% | |||||||
Market cap | 151,481,950 10.40% | 137,214,668 18.30% | 115,992,298 -15.19% | |||||||
EV | 92,501,950 | 71,656,668 | 52,065,298 | |||||||
EBITDA | 21,716,000 | 19,865,000 | 18,252,000 | |||||||
EV/EBITDA | 4.26 | 3.61 | 2.85 | |||||||
Interest | 118,000 | 94,000 | 89,000 | |||||||
Interest/NOPBT | 0.99% | 0.83% | 0.87% |